These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37848865)

  • 1. Effectiveness of a hysteroscopic tissue removal system device for hysteroscopic myomectomy on patients' quality of life: a randomized clinical trial.
    Tam T; Juarez L
    BMC Womens Health; 2023 Oct; 23(1):541. PubMed ID: 37848865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine-Artery Embolization or Myomectomy for Uterine Fibroids.
    Manyonda I; Belli AM; Lumsden MA; Moss J; McKinnon W; Middleton LJ; Cheed V; Wu O; Sirkeci F; Daniels JP; McPherson K;
    N Engl J Med; 2020 Jul; 383(5):440-451. PubMed ID: 32726530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
    Laughlin-Tommaso SK; Lu D; Thomas L; Diamond MP; Wallace K; Wegienka G; Vines AI; Anchan RM; Wang T; Maxwell GL; Jacoby V; Marsh EE; Spies JB; Nicholson WK; Stewart EA; Myers ER
    Am J Obstet Gynecol; 2020 Apr; 222(4):345.e1-345.e22. PubMed ID: 31678093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
    Anchan RM; Spies JB; Zhang S; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
    Am J Obstet Gynecol; 2023 Sep; 229(3):275.e1-275.e17. PubMed ID: 37244458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hysteroscopic myomectomy for submucosal type 2 fibroids with cold enucleation technique and complete fibroid extraction using a double-lumen intracervical cannula.
    Osorio W; Posada N; Cano J; Tamayo S; Giraldo J
    Fertil Steril; 2021 Feb; 115(2):522-524. PubMed ID: 33272627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life after myomectomy according to the surgical approach and MED12 mutation status.
    Äyräväinen A; Vahteristo M; Khamaiseh S; Heikkinen T; Ahvenainen T; Härkki P; Vahteristo P
    Eur J Obstet Gynecol Reprod Biol; 2024 Oct; 301():142-146. PubMed ID: 39137592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
    Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
    Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research.
    Coyne KS; Margolis MK; Murphy J; Spies J
    Value Health; 2012; 15(5):674-9. PubMed ID: 22867776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL).
    Harding G; Coyne KS; Thompson CL; Spies JB
    Health Qual Life Outcomes; 2008 Nov; 6():99. PubMed ID: 19014505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedural sedation and analgesia versus general anesthesia for hysteroscopic myomectomy (PROSECCO trial): A multicenter randomized controlled trial.
    van der Meulen JF; Bongers MY; van der Zee LG; Leemans JC; Duijnhoven RG; de Leeuw RA; Overdijk LE; Radder CM; van der Voet LF; Smeets NAC; van Vliet HAAM; Hehenkamp WJK; Manger AP; Lim AC; Peters LW; Horree N; Briët JM; van der Steeg JW; Coppus SFPJ; Kok HS
    PLoS Med; 2023 Dec; 20(12):e1004323. PubMed ID: 38153958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Fertility Goals on Long-term Quality of Life in Reproductive-aged Women Who Underwent Myomectomy versus Hysterectomy for Uterine Fibroids.
    Frisch EH; Mitchell J; Yao M; Llarena N; Omosigho UR; DeAngelo L; Arakelian M; Bradley L; Falcone T
    J Minim Invasive Gynecol; 2023 Aug; 30(8):642-651. PubMed ID: 37044261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B; Havelock J; Hemmings R; ;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-month outcomes for patients undergoing hysteroscopic morcellation of uterine polyps and myomas in an office or ambulatory surgical center.
    Rubino RJ; Lukes AS
    J Minim Invasive Gynecol; 2015 Feb; 22(2):285-90. PubMed ID: 25446547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
    McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
    Trials; 2014 Nov; 15():468. PubMed ID: 25432688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transrectal ultrasound-guided hysteroscopic myomectomy of submucosal myomas with a varying degree of myometrial penetration.
    Ludwin A; Ludwin I; Pityński K; Basta P; Basta A; Banas T; Jach R; Wiecheć M; Grabowska R; Stangel-Wójcikiewicz K; Milewicz T; Nocuń A
    J Minim Invasive Gynecol; 2013; 20(5):672-85. PubMed ID: 23850363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: The FEMME randomized controlled trial.
    Sirkeci F; Moss J; Belli AM; McPherson K; Daniels J; Manyonda I; Middleton L; Cheed V; Wu O; Lumsden MA;
    Int J Gynaecol Obstet; 2023 Feb; 160(2):492-501. PubMed ID: 36511801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Focused Ultrasound Surgery and Hysteroscopic Resection for Treatment of Submucosal Uterine Fibroids (FIGO Type 2).
    Hu L; Zhao JS; Xing C; Xue XL; Sun XL; Dang RF; Chen WZ; Wang ZB; Chen JY
    Ultrasound Med Biol; 2020 Jul; 46(7):1677-1685. PubMed ID: 32359807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire.
    Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K
    Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.